Strengthening immunisation systems and introduction of hepatitis B vaccine in Central and Eastern Europe and the Newly Independent States, 3rd meeting, Kyiv, Ukraine, May 25-28, 2004
Overall Goal:
Objectives of the meeting:
1) Provide participants with an overview of the current epidemiological situation of viral hepatitis infection worldwide and in the European Region of the World Health Organization (WHO)
2) Provide participants with an overview of the Global Alliance for Vaccines and Immunization (GAVI), the Vaccine Fund (VF) and related activities in the WHO European Region
3) Provide an overview of the current status of hepatitis B vaccination globally and in the WHO European Region
4) Discuss financial sustainability issues of hepatitis B vaccination in GAVI and non-GAVI countries and share country experience
5) Discuss status and options of vaccine procurement for non-GAVI countries in Central and Eastern Europe and the NIS
6) Review safety of vaccines, including hepatitis B vaccines, and vaccination and how to communicate on these topics
7) Discuss transition issues with the availability of monovalent and combined vaccines
8) Discuss the roles of various partner agencies and organisations in vaccination programmes
Planned achievements of the meeting:
- an update on the current situation and issues in the participating countries in terms of hepatitis B epidemiology and hepatitis B vaccination programmes
- a better understanding of the safety issues of hepatitis B vaccines and vaccination programmes at country level
- a better understanding of the financial sustainability of hepatitis B vaccines at country level
Tuesday, 25 May 2004
Session 1: Opening session
Chair: André Meheus, Tore Godal,
18.00-19.00 Welcome by:
Olga Lapushenko, Ministry of Health, Ukraine
Nedret Emiroglu, WHO
Dragoslav Popovic, UNICEF
Mark Kane, Children’s Vaccine Program
Review of the objectives of the meeting and technical introduction
19.00-21.00 WELCOME RECEPTION
Wednesday, 26 May 2004
Session 2 : General Introduction
Chair: Hal Margolis, Olga Lapushenko
09.00-09.20 Global Epidemiology and prevention of hepatitis B (pdf, 781 Kb) Steven Wiersma, WHO
09.20-09.40 Overview of GAVI and the Vaccine Fund (pdf, 1103 Kb) Tore Godal, GAVI
09.40-10.00 GAVI in the WHO European Region: results, current situation, and future (pdf, 1290 Kb) Andrei Lobanov, WHO
10.00-10.30 Coffee break
Session 3: Epidemiology and prevention of viral hepatitis and
Haemophilus influenzae type b
Chair: Mark Kane, Vladimir Davidiants
10.30-11.00 Epidemiology of hepatitis B and vaccination programmes in the WHO European Region (pdf, 2223 Kb) Nedret Emiroglu, WHO
11.00-11.30 Hepatitis C epidemiology in CEE and NIS countries (pdf, 346 Kb) Hal Margolis, CDC
11.30-12.00 HBV, HCV, and HIV integrated programmes (pdf, 858 Kb) Michael Favorov, CDC
12.00-14.00 LUNCH
14.00-14.30 Burden of disease of Haemophilus influenzae type b in the WHO European Region (pdf, 725 Kb) Andrei Lobanov, WHO
Session 4: Country experiences: hepatitis B Prevention strategies and programme evaluation
Chair: Steven Wiersma, Ljubomir Kumanov
14.30-14.50 Introduction of a newborn hepatitis B immunisation programme in Turkey (pdf, 281 Kb) Ebru Usta and Selim Badur, Turkey
14.50-15.10 Achievements with newborn and catch up hepatitis B immunisation programme in Kazakhstan (pdf, 377 Kb) Tatiana Surdina, Kazakhstan
15.10-15.30 Assessment of implementation of the hepatitis B prevention programme in Georgia (pdf, 166 Kb) Lia Dzhabidze, Georgia
15.30-16.00 Coffee break
16.00-16.20 Evaluation of hepatitis B prevention strategies in the Russian Federation (pdf, 257 Kb) Marina Shevyreva, Russian Federation
16.20-16.40 Experience with sentinel surveillance in Kyrgyzstan (pdf, 380 Kb) Rafik Usmanov, Kyrgyzstan
16.40-17.00 Acute Viral Hepatitis Surveillance for Hepatitis B Vaccine Evaluation Program (ppt, 161 Kb) Liudmila Mosin, CDC
Thursday, 27 May 2004
Session 5 : Safety issues
Chair: Paolo Bonanni, Ramaz Urushadze
09.00-09.20 Safety and quality of hepatitis B vaccines: Frequently asked questions in the WHO European Region (pdf, 515 Kb) Philippe Duclos, WHO
09.20-09.40 The importance of communication on immunisation safety (pdf, 499 Kb) Dragoslav Popovic, UNICEF
09.40-10.00 Injection safety of immunisation in the WHO European Region (pdf, 1096 Kb) Denis Maire, WHO
10.00-10.15 Blood safety in Central Asia Region (pdf, 664 Kb) Aliya Jumagulova, CDC
10.15-10.30 Safe sharps waste collection and management in Samarkand, Uzbekistan (pdf, 1395 Kb) Erkin Musabaev, Uzbekistan
10.30-11.00 Discussions
11.00-11.30 Coffee break
Session 6: Strengthening immunisation systems: procurement and financing
Chair: Andrei Lobanov, Ludmila Shteinke
11.30-11.50 Vaccine supply in CEE and NIS (pdf, 949 Kb), Katinka Aanjesen, UNICEF
11.50-11.55 Vaccine procurement European Perspectives (pdf, 198 Kb) Denis Maire, WHO
11.50-12.10 Potential role of group procurement in the WHO European Region (pdf, 262 Kb) Alan Brooks, CVP/PATH
12.10-12.30 Discussions
12.30-14.00 LUNCH
14.00-14.20 Financial sustainability planning (pdf, 173 Kb) Viktor Galyada, CVP/PATH
14.20-14.35 Financial sustainability planning of Uzbekistan (pdf, 217 Kb) Dilorom Tursunova, Uzbekistan
14.35-14.50 e-learning resource to strengthen financial planning of immunization (ppt, 494 Kb) Alan Brooks, CVP/PATH
14.50-15.10 Discussions
15.10-15.30 Coffee break
Session 7A: Technical Workshop: How to monitor and evaluate hepatitis B immunisation programmes and to set surveillance targets
Moderators: Susan Goldstein, Sergei Deshevoi, Steven Wiersma
15.30-15.55 Overview of methods to evaluate the impact hepatitis B immunization programs (pdf, 354 Kb) Susan Goldstein, CDC
15.55-16.20 Practical aspects of conducting acute disease surveillance Rafik Usmanov, Kyrgyzstan
16.20-16.45 Laboratory aspects of acute disease surveillance and the need for QA/QC (pdf, 354 Kb) Tatiana Kalashnikova, CDC
16.45-17.10 Protocol to conduct serologic surveys Luidmila Mosina, CDC
17.10- 17.35 WHO protocol for serologic surveillance (pdf, 104 Kb) Steven Wiersma, WHO
17.35-18.00 Open Discussion
Session 7B : Technical Workshop: hepatitis B vaccines
Moderators: Daniel Lavanchy, Wolfgang Jilg, Paolo Bonanni,
15.30-15.40 Introduction
15.40-16.00 Birth dose: what is possible in view of other vaccines, combined vaccines, etc Reflections on schedules, dosage, vaccines and inter-changeability of hepatitis B vaccines (pdf, 224 Kb) Pierre Van Damme, VHPB
16.00-16.30 Duration of protection after hepatitis B vaccination: current status (pdf, 194 Kb) Wolfgang Jilg, VHPB
16.30-16.45 Current experience in Italy (pdf, 328 Kb) Paolo Bonanni, VHPB
16.45-17.00 Review of current recommendations regarding booster vaccination (pdf, 202 Kb) Daniel Lavanchy, WHO
17.00-17.30 Country experience on current vaccination policy: booster, schedules, vaccine, doses, etc.:
Workshop discussion with country participants
17.30-17.50 Pre- and post-vaccination testing and the issue of non-responders (pdf, 153 Kb) Fransisco Averhoff, CDC
17.50-18.00 Final open questions and answers to facilitators/ conclusions
Session 7c: Technical Workshop: How to manage a vaccine safety crisis in your country: what to do, what to avoid? (advocacy, social mobilization)
Moderators: Dragoslav Popovic, Philippe Duclos
15.30-15.45 Introduction of participants, objectives of the workshop, agenda
15.45-15.55 Why and how to deal with media?
15.55-16.35 Press Conference: Role play
16.35-17.20 Case studies: Response to safety crisis and development of a checklist on "crisis management" Group Work
17.20-17.40 Rapport from the working groups/discussion
17.40-18.00 How to access major sources in communication for immunization/Discussion
Session 7d: GAVI Workshop: Financial sustainability plans (FSP)
Moderators: Andrei Lobanov, Viktor Galyada, Alan Brooks
15.30-15.45 Introduction
15.45-16.25 Countries briefly describe the development process
16.25-16.40 Implementation of FSP in Kyrgyzstan (pdf, 290 Kb) Ludmila Shteinke, Kyrgyztan
16.40-17.15 Countries describe what is being done to maintain rolling financial planning for immunization, including implement strategies in the FSP
17.15-17.45 Getting the 2004 process started
17.45-18.00 Final open questions and answers to facilitators or other countries
Friday, 28 May 2004
Session 8 : Feedback of the workshops
Chair: Nedret Emiroglu, Dragoslav Popovic
09.00-09.15 Feedback on workshop 7A: How to monitoring and evaluate hepatitis B immunisation programmes and set surveillance targets (pdf, 87 Kb)
09.15-09.25 Discussion
09.25-09.40 Feedback on workshop 7B: Technical aspects of hepatitis B vaccines (pdf, 220 Kb)
09.40-09.50 Discussion
09.50-10.05 Feedback on workshop 7C: How to manage a vaccine safety crisis in your country (pdf, 180 Kb)
10.05-10.15 Discussion
10.15-10.30 Feedback on workshop 7D: Financial sustainability plans (pdf, 71 Kb)
10.30-10.40 Discussion
10.40-11.10 Coffee break
Session 9: Conclusions of the Meeting and Closing Remarks
Chair: Nedret Emiroglu, Dragoslav Popovic
11.10-12.00 Conclusions and summary of the meeting (pdf, 145 Kb) Alexandra Levitt